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This paper presents a model-based investigation of mechanisms
underlying the reduction of mismatch negativity (MMN) amplitudes
under the NMDA-receptor antagonist ketamine. We applied
dynamic causal modeling and Bayesian model selection to data
from a recent ketamine study of the roving MMN paradigm, using a
cross-over, double-blind, placebo-controlled design. Our modeling
was guided by a predictive coding framework that uniﬁes contem-
porary “adaptation” and “model adjustment” MMN theories. Com-
paring a series of dynamic causal models that allowed for different
expressions of neuronal adaptation and synaptic plasticity, we ob-
tained 3 major results: 1) We replicated previous results that both
adaptation and short-term plasticity are necessary to explain MMN
generation per se; 2) we found signiﬁcant ketamine effects on sy-
naptic plasticity, but not adaptation, and a selective ketamine effect
on the forward connection from left primary auditory cortex to
superior temporal gyrus; 3) this model-based estimate of ketamine
effects on synaptic plasticity correlated signiﬁcantly with ratings of
ketamine-induced impairments in cognition and control. Our model-
ing approach thus suggests a concrete mechanism for ketamine
effects on MMN that correlates with drug-induced psychopathol-
ogy. More generally, this demonstrates the potential of modeling for
inferring on synaptic physiology, and its pharmacological modu-
lation, from electroencephalography data.
Keywords: Bayesian model selection, dynamic causal modeling, effective
connectivity, mismatch negativity, NMDA receptor
Introduction
The mismatch negativity (MMN) is an event-related potential
(ERP), measured with electrophysiological techniques such as
electroencephalography (EEG) or magnetoencephalography
(MEG), observed in response to the violation of a statistical
regularity. Operationally, it is deﬁned as the difference wave-
form obtained by subtracting the ERP to predicted (“stan-
dard”) stimuli from unpredicted (“deviant”) stimuli. While it
has been studied most intensively in the auditory domain, it
has also been elicited using visual and somatosensory stimuli
(Astikainen et al. 2004; Czigler et al. 2004). Ever since its
initial description in 1978 (Naatanen et al. 1978), the MMN
has played an increasingly important role in cognitive neuro-
science. Traditionally, it was seen to reﬂect a basic process of
memory trace formation (Naatanen et al. 2001), which
enables automatic, pre-attentive novelty or change detection
(Tiitinen et al. 1994; Naatanen 2000). More recently, the MMN
has been interpreted as a electrophysiological index of sur-
prise or prediction error and treated as a paradigmatic
example of perceptual inference and learning within a
general hierarchical Bayesian framework of brain function,
namely, predictive coding (Rao and Ballard 1999; Friston
2005) that can be regarded as an instance of the free-energy
principle (Friston 2009).
Beyond cognitive neuroscience and theories of brain func-
tion, the MMN has attracted a lot of attention because it is
altered in several brain disorders (Naatanen 2003) with, in
particular, signiﬁcant reductions in schizophrenia patients
(Baldeweg et al. 2002, 2004; Umbricht and Krljes 2005). The
MMN is well-suited as a potential index of pathophysiology
because it can be obtained with relatively little effort and is
robust against a number of factors that can confound the
interpretation of diagnostically relevant measures from cogni-
tive paradigms, such as attentional state or vigilance (Naata-
nen et al. 2001). The clinical utility of the MMN is further
established by remarkably consistent ﬁndings from neuro-
pharmacological studies, rendering it potentially informative
with regard to pathophysiology and treatment: Over the past 2
decades, numerous pharmacological experiments in animals
and humans have indicated that MMN expression can be
strongly reduced by antagonizing NMDA receptors (NMDAR;
Javitt et al. 1996; Umbricht et al. 2000; Kreitschmann-
Andermahr et al. 2001; Ehrlichman et al. 2008; Heekeren et al.
2008).
Understanding the NMDAR-dependence of the MMN is best
pursued within a comprehensive theory of the physiological
and computational mechanisms that generate MMN
responses. One such theory is the so-called “adaptation
hypothesis”, which postulates that the MMN arises from adap-
tation mechanisms in tonotopically organized parts of the
auditory system, that is, neurons in the primary auditory
cortex that are repeatedly excited by auditory stimuli of the
same frequency (May et al. 1999; Jääskeläinen et al. 2004; Ula-
novsky et al. 2004). Biophysically, this appeals to mechanisms
such as rapid synaptic depression (Zucker and Regehr 2002)
or spike-frequency adaptation (Faber and Sah 2003). An
alternative perspective on MMN mechanisms is the “model ad-
justment hypothesis”, which views the MMN as a response re-
ﬂecting the update of an environmental model that is
represented by a network of temporo-frontal areas and recon-
ﬁgures in the light of unexpected sensory events (Winkler
et al. 1996; Winkler 2007). Neurophysiologically, this theory
speaks to the importance of short-term plasticity of glutama-
tergic long-range connections between temporal and frontal
areas. More recently, a “free-energy theory” of the MMN was
formulated that uniﬁes both the adaptation and model adap-
tation hypothesis and suggests an overarching physiological
and computational process that requires both adaptation that
is intrinsic to cortical sources and short-term plasticity in ex-
trinsic connections between sources (Garrido et al. 2008;
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Garrido, Kilner, Stephan, et al. 2009). This theory interprets
the MMN as a prediction error signal (generated by pyramidal
neurons in supragranular layers) during predictive coding in
the auditory processing hierarchy, where each level attempts
to minimize the discrepancy between bottom-up inputs from
the level below and top-down predictions from the level
above. By recurrent message passing across levels and predic-
tion error-dependent synaptic plasticity, this circuit minimizes
free-energy (an approximation to the information theoretic
measure of surprise) across the entire hierarchy, enabling in-
ference about the causes of sensory input and optimal learn-
ing about statistical regularities (Friston 2009). Importantly,
the free-energy theory of the MMN incorporates the 2 key
physiological mechanisms implied by the 2 previous theories:
local adaptation and short-term plasticity of inter-regional glu-
tamatergic synaptic connections. The former controls the post-
synaptic gain of neurons encoding prediction error (such that
inputs with low precision or high uncertainty have less
impact on predictions), while the latter optimizes inter-
regional synaptic weights during learning and thus regulates
the transmission of predictions and their errors across the
hierarchy.
While the free-energy principle is a very generic theory of
brain function (Friston 2010), it has been particularly useful
for framing studies of MMN mechanisms. Of particular rel-
evance for the present study is that both of the key processes
described above—adaptation and short-term plasticity of glu-
tamatergic connections—are regulated by NMDARs. The free-
energy formulation thus offers an opportunity to address the
question, from a model-based perspective, which synaptic
mechanism may underlie the empirically well-established
NMDAR-mediated reduction of the MMN. It is conceivable
that this effect could be expressed entirely at the level of neur-
onal adaptation because spike-frequency adaptation results
from potassium channel-dependent hyperpolarization which,
in turn, relies on intracellular calcium inﬂux that is modulated
by NMDAR status (Faber and Sah 2003). On the other hand, it
is equally conceivable that the NMDAR-mediated MMN
reduction results from aberrant short-term plasticity of inter-
regional glutamatergic connections. This is because activation
of NMDARs can lead to rapid changes in the strength of gluta-
matergic synapses, for example, via phosphorylation of AMPA
receptors (AMPARs; Wang et al. 2005). A third option is that
both mechanisms contribute to empirically observed NMDAR
effects on MMN expression.
Clearly, these competing accounts cannot be disentangled
by traditional ERP analyses that rely on simple subtraction of
evoked responses. Instead, we need to evaluate the relative
plausibility of different physiologically interpretable models
that can be ﬁtted to empirically measured MMN responses.
This allows us to assess the relative contributions from adap-
tation and short-term plasticity of glutamatergic connections,
and how they change under NMDAR antagonists.
A general framework for model-based assessment of com-
peting theories about neuronal circuits is dynamic causal
modeling (DCM; Friston et al. 2003; Stephan et al. 2010).
DCM is a generic Bayesian system identiﬁcation technique
that has gained popularity in neuroimaging and electrophysi-
ology over the past few years and allows for inference on
“hidden” neurophysiological mechanisms that generated ob-
served measures, such as blood oxygen-level–dependent
signal in functional magnetic resonance imaging (fMRI) or
evoked responses measured with EEG. The key idea here is to
formulate a simpliﬁed model of neuronal population
responses and combine this with a modality-speciﬁc forward
model such that one can predict the measurement that would
arise from any particular neuronal circuit. Given such a gen-
erative model and known experimental perturbations
(stimuli), one can invert the model and thereby compute the
posterior probability of the model parameters, given the data.
Furthermore, alternative models embodying competing
hypotheses about the mechanisms generating the data can be
evaluated using their model evidence, a principled measure
of the balance between model ﬁt and model complexity
(Penny et al. 2004).
While DCM has been formulated for different modalities
(cf. Stephan et al. 2007; Kiebel et al. 2009), its current
implementation for ERPs represents a neural mass formu-
lation of interacting cortical sources (David et al. 2006), with
distinct representations of adaptation and synaptic plasticity
that have proven very useful in previous MMN studies (Kiebel
et al. 2007; Garrido et al. 2008; Garrido, Kilner, Kiebel, et al.
2009). In this paper, we use this implementation of DCM for
inferring on the physiological mechanisms that underlie em-
pirically measured reductions of MMN amplitude under the
inﬂuence of the NMDAR antagonist ketamine. The data ana-
lyzed here were from a recent study by Schmidt et al. (2012)
who examined 19 healthy volunteers with a roving MMN
paradigm (Haenschel et al. 2005; Garrido et al. 2008) on 2
sessions, using a cross-over, double-blind, placebo-controlled
design. As previously reported, the ERP analyses of these data
indicated a signiﬁcant reduction of the MMN at fronto-central
electrodes following ketamine administration (Schmidt et al.
2012), which is consistent with a number of previously pub-
lished reports in humans, using conventional (non-roving)
MMN paradigms (Umbricht et al. 2000, 2002; Heekeren et al.
2008).
In this paper, we apply DCM and Bayesian model selection
(BMS) to the data from Schmidt et al. (2012) to address the
following 3 questions. First, can we replicate the results of
previous (non-pharmacological) DCM studies of the MMN
that evaluated a set of competing models inspired by the free-
energy formulation (Garrido et al. 2008; Garrido, Kilner,
Stephan, et al. 2009)? Secondly, which of the 2 mechanisms
of interest—intrinsic adaptation or extrinsic short-term gluta-
matergic plasticity—contributes most to explaining ketamine
effects on MMN expression, and are these mechanisms re-
gionally speciﬁc? Finally, can we validate our model-based ap-
proach by ﬁnding a correlation between model parameter
estimates and cognitive measures altered by ketamine?
In brief, 1) we replicate previous DCM results from non-
pharmacological MMN studies that both adaptation and short-
term plasticity are necessary to explain MMN expression per
se, 2) we ﬁnd signiﬁcant ketamine effects on synaptic plas-
ticity, but not adaptation, and observe a selective ketamine
effect on forward connections from the left primary auditory
cortex, and ﬁnally, 3) we observe a signiﬁcant correlation
between ketamine-induced changes in plasticity of auditory
forward connections and introspective measures of cognition.
Materials and Methods
The participants, drug administration, and data acquisition have pre-
viously been described in Schmidt et al. (2012) and the interested
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reader is referred to this paper for details. Here, we summarize the
most important aspects and provide details of data analysis with DCM
and BMS.
Subjects
This study was approved by the Ethics Committee of the University
Hospital of Psychiatry, Zurich. After receiving written and oral
descriptions of the aim of the study, all participants gave written
informed consent statements before inclusion in the study. The use
of psychoactive drugs was approved by the Swiss Federal Health
Ofﬁce, Department of Pharmacology and Narcotics (DPN), Bern,
Switzerland.
Healthy subjects were recruited at the local university and technical
college through advertisement (N = 19; male: 12, mean age = 26 ± 5.09
years). The study of Schmidt et al. (2012) also included a group of
subjects receiving psilocybin versus placebo. As no effect of psilocy-
bin on the MMN was found, this group was not included in the
present study.
Prior to inclusion, the subjects’ physical health was conﬁrmed by
medical history, clinical examination, electrocardiography, and blood
analysis. To ascertain the subjects’ mental status, all subjects were
screened by the diagnostic expert system (Wittchen and Pﬁster 1997),
using a semi-structured psychiatric interview, and the Hopkins
Symptom Checklist (SCL-90–R; Derogatis 1994). Furthermore, sub-
jects also underwent the Mini-International Neuropsychiatric Inter-
view (MINI), a short structured psychiatric interview (Sheehan et al.
1998). We veriﬁed the absence of a history of drug dependence or
present drug abuse by urine drug screening and a questionnaire that
assessed previous drug consumption.
Drug Administration and Psychometric Assessment
of S-Ketamine State
Subjects underwent 2 sessions (placebo and S-ketamine) in a counter-
balanced fashion at an interval of at least 2 weeks. Both subjects and
the principal investigator were blind to drug order. Subjects were
monitored and under constant supervision until all drug effects had
worn off, and were then released into the custody of a partner or
immediate relative. For the S-ketamine/placebo infusion, an in-
dwelling catheter was placed in the antecubital vein of the non-
dominant arm. Once the subject was ready, a bolus injection of 10 mg
over 5 min was delivered. Following a 1 min break, a continuous infu-
sion with 0.006 mg/kg per min was administered over 80 min.
To keep S-ketamine plasma level fairly constant, the dose was
reduced every 10 min by 10% (Feng et al. 1995; Vollenweider et al.
1997). In the placebo session, the same procedure was followed and
an infusion of physiological sodium chloride solution and 5% glucose
was administered.
The Altered State of Consciousness (ASC) questionnaire, a visual
analog and self-rating scale, was used to assess the subjective effects
of S-ketamine (Dittrich 1998). A recent evaluation study of the ASC
questionnaires has constructed 11 new lower order scales (Studerus
et al. 2010), which were analyzed in this study.
Experimental Design
Electroencephalographic (EEG) activity was recorded during an audi-
tory “roving” oddball paradigm, originally developed by Cowan et al.
(1993) and subsequently modiﬁed by Baldeweg et al. (2004), to
assess the MMN response. Acoustic stimuli were generated using the
E-prime software (Schneider et al. 2002) and were presented binau-
rally through headphones.
The stimuli consisted of seamlessly connected trains of pure sinu-
soidal tones with a roving frequency structure. Within each stimulus
train, all tones were of one frequency and were followed by a train of
tones of a different frequency. The ﬁrst tone of a train represented the
deviant, which became a standard tone after a few repetitions. There-
fore, the deviant and standard tones had exactly the same physical
properties within one stimulus train, differing only in the number of
times they had been presented in the recent past. The number of
times the same tone was presented within one stimulus train varied
pseudo-randomly between 1 and 11 (t = 1–11). The probability that
the same tone was presented in one stimulus train was 1) 2.5% for
trains with 1 or 2 identical tones, 2) 3.75% for trains with 3 or 4 iden-
tical tones, and 3) 12.5% for trains with 5–11 identical tones. In other
words, 5% of all stimulus trains consisted of 1–2 identical tones, 7.5%
of all stimulus trains consisted of 3–4 identical stimuli, and 87.5% of
all stimulus trains consisted of 5–11 identical stimuli. The frequency
of the tones varied from 500 to 800 Hz in random steps with integer
multiples of 50 Hz, tone duration was set at 70 ms, and the inter-
stimulus interval was 500 ms.
In parallel, subjects performed a distracting visual task and were
instructed to ignore the sounds. This follows the suggestion that MMN
assessment is optimal when the subject’s attention is directed away
from the auditory domain (Naatanen 2000). The task consisted of
button-press responses whenever a ﬁxation cross changed its lumi-
nance, which occurred pseudo-randomly every 2–5 s (not coinciding
with auditory changes). The experimental session lasted approxi-
mately 15 min.
Data Acquisition and Preprocessing
The EEG was recorded at a sampling rate of 512 Hz using a Biosemi
system with 64 scalp electrodes. The horizontal electro-occulogram
(EOG) was recorded from electrodes attached on the outer canthus of
each eye. Similarly, the vertical EOG was recorded from electrodes
attached infraorbitally and supraorbitally to the left eye.
Pre-processing and data analysis was performed using SPM8
(http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/). Continuous EEG
recordings were referenced to the average, down-sampled to 300 Hz,
and bandpass ﬁltered between 0.5 and 30 Hz. The data were then
epoched into 500 ms segments using a peri-stimulus window of 100
ms. For each subject and in each condition, 2 trial types were deﬁned,
the deviant trial (ﬁrst tone within a new train) and a standard trial (op-
erationally deﬁned as the sixth tone, as in Garrido et al. (2008)). The
artifact rejection procedure used a thresholding approach to detect
problematic trials or channels. Trials in which the signal recorded at
any of the channels exceeded 80 µV relative to the pre-stimulus base-
line were removed from subsequent analysis. Most of the artifacts that
were detected reﬂected vertical and horizontal eye movements, which
were monitored using ocular electrodes. The average number of
artifact-free trials was 124 and 172 for standard and deviant trials in
the placebo condition, and 153 and 207 for standard and deviant trials
in the ketamine condition. Grand averages were computed using
robust averaging, a weighted least squares procedure that incorporates
a weighting matrix into the estimation so that outlier values exhibit
less inﬂuence on the overall mean (Wager et al. 2005).
The data were subject to standard analyses using statistical para-
metric mapping (SPM)—over channels and peri-stimulus time—to es-
tablish condition (standard vs. oddball) effects and any interaction
with ketamine at the between subject level. The same data were then
subject to dynamical causal modeling in an attempt to explain the
differences observed in terms of adaptation and changes in extrinsic
connectivity. For the SPM analyses, the averaged data from each trial
type and each condition were converted to scalp images for all 64
channels and 151 time points using a voxel size of 4.25 × 5.38 × 3.33
mm. The images were constructed using linear interpolation for
(removed) bad channels and smoothing to accommodate for between-
subject spatial and temporal variability in channel space.
DCM was applied to the preprocessed channel data to explain ob-
served responses in source states. For computational expediency, all
dynamic causal models (see below) were computed on a reduced
channel space that corresponded to 8 channel mixtures or spatial
modes. The 8 spatial modes were calculated using singular value
decomposition of the channel data over a temporal window of inter-
est. Following Garrido et al. (2008), the temporal window of interest
was conﬁned to 0–250 ms post-stimulus to ensure selective modeling
of the MMN response (as opposed to later components).
Dynamic Causal Modeling
Neurophysiologically plausible forward models are essential for un-
derstanding how ERPs are generated. One such approach is DCM that
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was originally developed for connectivity analysis of fMRI data
(Friston et al. 2003) and was subsequently implemented for a range
of other data modalities and features, such as ERPs measured by EEG
(David et al. 2006). DCM uses a biologically informed causal model to
make inferences about the underlying neural mechanisms that gener-
ate observed event-related responses. This approach provides an
important advance over conventional source reconstruction tech-
niques for ERP data because it places neurobiological constraints on
the model inversion, in which the parameters of the reconstruction
have a speciﬁc neuronal interpretation. These parameters describe,
for example, the synaptic coupling strength among sources and post-
synaptic gain, and how these properties depend upon stimulus attri-
butes or experimental manipulations (David et al. 2006; Kiebel et al.
2006).
The implementation of DCM for ERPs in SPM8 uses a neural mass
model of a cortical source (Jansen and Rit 1995) that contains interact-
ing inhibitory and excitatory subpopulations of neurons. Speciﬁcally,
each source is described in terms of the average post-membrane
potentials and ﬁring rates of 3 neuronal subpopulations of pyramidal
cells, spiny stellate cells, and inhibitory interneurons. The cortical
sources are linked by forward, lateral, and backward connections
(Linn et al. 1999) and conform to a hierarchical model of intrinsic and
extrinsic connections within and between multiple sources as de-
scribed in previous studies (David et al. 2005; Nee et al. 2007).
To estimate the model parameters that best explain how the ob-
served data were generated, DCM inverts a spatiotemporal model cov-
ering all sensors or spatial modes and the temporal window of
interest. The neural parameters describe synaptic connectivity
strengths, post-synaptic gain, propagation delays among sources, and
various synaptic rate constants. The spatial parameters, on the other
hand, specify the location and orientation of equivalent current
dipoles (ECDs). We used a 4 concentric sphere head model with hom-
ogenous and isotropic conductivity as an approximation to the brain,
the cerebrospinal ﬂuid, skull and scalp surfaces. We speciﬁed an ECD
model with uninformed priors about the dipole orientations and in-
formed priors about the source locations (Penny 2012), using the
same coordinates as Garrido et al. (2008) for deﬁning prior surface
location means with a prior variance of 16 mm2. The moment
(orientation) parameters had prior means of zero and a variance of
256 mm2 in each direction, which is equivalent to assuming unin-
formed priors on the orientations of the dipoles.
Bayesian inversion of the combined neuronal and spatial model
provides a posterior distribution for each parameter whose variance
represents the uncertainty about the parameter after observing the
data. Furthermore, the uncertainty about the model itself is addressed
using a Bayesian model comparison based on an approximation to
the model evidence. These procedures are explained in detail else-
where (Penny et al. 2004; Stephan et al. 2009) and are brieﬂy sum-
marized below.
Model Speciﬁcation
DCM is a hypothesis driven method that does not explore all possible
models, but tests a speciﬁed model space based on prior knowledge
about the system of interest. The network architectures that we tested
in the present study were motivated by the results of previous MMN
examinations (Rinne et al. 2000; Opitz et al. 2002; Doeller et al. 2003;
Grau et al. 2007). These studies suggest that the main cortical genera-
tors of the MMN include the bilateral primary auditory cortex (A1),
the bilateral superior temporal gyrus (STG), and the right inferior
frontal gyrus (IFG). The coordinates used for the speciﬁcation of our
ECD model were informed by the above studies and identical to the
ones previously used by Garrido et al. (2008) in the original DCM
examination of the roving MMN.
In this study, we compared 8 distinct models that might underlie
the generation of MMN in response to a deviant tone. These models
were created by systematic combinations of the 2 key mechanisms
proposed by predictive coding schemes under the free-energy prin-
ciple. The ﬁrst mechanism was short-term plasticity of glutamatergic
long-range connections. In DCMs of the MMN, this is typically
modeled by allowing for a modulation of the synaptic coupling
strength of inter-regional forward and backward connections when
the deviant tone is presented (cf. Garrido et al. 2007, 2008). The cor-
responding DCM parameters express (as a multiplicative factor or
scaling coefﬁcient) the coupling change relative to the standard tone.
We allowed for different expression of this type of plasticity, creating
4 models: No modulation of connections by the deviant tone (model
1), modulation of either forward or backward connections among A1,
STG, and IFG (models 2 and 3), and modulation of both forward and
backward connections among the 3 brain regions (model 4). With
these 4 models, we hypothesized that the differences between the
deviant and the standard are caused by short-term plasticity of con-
nections within the temporofrontal network, representing the reconﬁ-
guration of this network in response to prediction error or surprise
(cf. model adjustment).
The second mechanism represented by our models concerned
neuronal adaptation. That is, in models 5 through 8 we repeated the
same variations in synaptic plasticity as for the ﬁrst 4 models, but
additionally we allowed for variations in adaptation, expressed in
terms of deviant-induced modulation of the post-synaptic gain (re-
sponsiveness or excitability) in left and right A1 (Fig. 4A). This ad-
dressed the adaptation hypothesis, which postulates that the MMN
arises predominantly from post-synaptic mechanisms such as spike-
frequency adaptation as a result of an increase in calcium-dependent
potassium conductance (May et al. 1999; Ulanovsky et al. 2004). In
DCMs of the MMN, a lumped representation of adaptation mechan-
isms can be achieved by allowing for a modulation of post-synaptic
gain parameters (this has previously also been referred to as modu-
lation of “intrinsic connections”; Kiebel et al. 2007). Thus, models 5
through 8 examine the hypothesis of both frontotemporal interactions
and local adaptation within A1 as the neural mechanisms underlying
the generation of the MMN response.
Overall, the 8 models tested here are similar, but not identical, to
the 6 models considered by Garrido et al. (2008). We used the same
type of DCM, time window (0–250 ms), number of spatial modes, and
dimensions of model space (i.e., adaptation and synaptic plasticity).
In addition to Garrido et al. (2008), however, we also tested models
without synaptic plasticity anywhere in the network (models 1 and 5;
Fig. 4A) and introduced additional inter-hemispheric connections
between A1 and STG, respectively, in both hemispheres (Fig. 4A).
Statistical Analysis
The statistical analyses employed in this paper were based on the
standard 2-stage (summary statistics) approach in DCM, that is, model
selection followed by interrogation of posterior estimates (Stephan
et al. 2010). In the ﬁrst stage, BMS was used to determine the optimal
network architecture underlying electrophysiological responses to
auditory stimulation. In a second stage, posterior parameter estimates
were examined to detect differences between placebo and ketamine
conditions. This second stage used the posterior means averaged over
the DCMs of each subject (Bayesian model averaging, BMA) as the
dependent variables for a multivariate Hotelling’s T2 test and sub-
sequent univariate t-tests (see below for details).
Bayesian Model Selection and Bayesian Model Averaging
From a Bayesian perspective, alternative models that represent com-
peting hypotheses about the mechanisms generating observed data
are evaluated by comparing their (log) evidence. The log evidence
corresponds to the negative surprise about the data or the (log) prob-
ability of the data given a model. It represents a principled measure,
derived from probability theory, of the balance between model ﬁt and
model complexity. Since it cannot be computed analytically except
for linear Gaussian models, approximations to the log evidence are
usually required. The approximation used here is the (negative) free
energy that provides a bound approximation on the log evidence and
can be obtained using Variational Bayes (Friston et al. 2007).
The evidence can be decomposed into 2 components: The accu-
racy term, which quantiﬁes the data ﬁt, and a complexity term, which
penalizes models with many degrees of freedom (e.g., many and/or
uninformed parameters). The best model given the data is the one
with the largest log model evidence, lnp(y|m) (assuming a uniform
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prior over all models). Models can be compared by computing evi-
dence ratios (Bayes factors) or log evidence differences. Following
conventional classiﬁcations (Kass and Raftery 1995), one concludes
that there is strong evidence in favor of a model if the difference in
log evidence is >3 compared with another model (i.e., a Bayes factor
of 20).
Furthermore, inference about general characteristics of model ar-
chitecture can be obtained by using family-based inference, which
compares sets of models grouped by architectural properties
(Heresco-Levy et al. 2007). In the present study, we used family level
inference to determine whether the modulation of post-synaptic gain
in bilateral A1 constituted an important addition to the model archi-
tecture. Thus, we speciﬁed 2 model families, the ﬁrst without and the
second with post-synaptic gain modulation present at the level of
bilateral A1. We performed family-wise inference, using a random
effects approach, which is robust to potential outliers in the popu-
lation (Stephan et al. 2009). Prior to the subsequent analysis of differ-
ences in posterior parameter estimates across drug conditions, we
used BMA (Penny et al. 2010) that averages over models, weighted by
the posterior model probabilities. In this way, BMA provides par-
ameter estimates that account for model uncertainty.
Analysis of Model Parameter Estimates
Following BMA, we used the resulting posterior means from the aver-
aged DCMs for examining differences in deviant-induced changes in
adaptation (post-synaptic gain) and synaptic plasticity (parameterized
in terms of condition dependent coupling changes) between placebo
and ketamine conditions. First, we used a multivariate Hotelling’s T2
test, testing whether the 2 sets of parameter estimates encoding neur-
onal adaptation and short-term synaptic plasticity, respectively, were
signiﬁcantly different between ketamine and placebo conditions. This
drug-induced difference was signiﬁcant for the parameters represent-
ing synaptic plasticity, but not for neuronal adaptation. Based on this
result we used, in a second step, univariate post hoc t-tests, asking
which of the 6 forward and backward connections in the model con-
tributed individually to explain the ketamine effects. We Bonferroni-
corrected the results for the number of parameters tested. Finally, in a
third step, we used a simple regression analysis to examine the
relationship between the model parameters showing signiﬁcant
changes under ketamine and the independent ratings on the ASC
questionnaire after ketamine administration.
Results
MMN Responses Due to Repetition Effects
A conventional analysis of MMN amplitudes and latencies
from this group of subjects has been presented by Schmidt
et al. (2012). Here, we complement these analyses by a spatio-
temporal characterization of the MMN response using SPM (in
sensor space) and whole-brain correction for multiple tests
(family-wise error correction using Gaussian random ﬁeld
theory as implemented in SPM8). The goal of this initial
analysis was to verify the presence of a MMN response for
each subject and each condition, prior to subsequent model-
ing. Two of 19 subjects failed to show a signiﬁcant MMN
response in both placebo and ketamine conditions and were
therefore excluded from subsequent DCM analyses. In the
placebo condition, the MMN response was observed over
frontal and central electrodes between 110 and 220 ms.
Figure 1A illustrates the grand mean responses averaged
across all subjects in the placebo condition, comparing
responses to “deviant” trials (ﬁrst tone within stimulus trains,
dashed lines) with responses to “standard” trials (sixth tone,
solid black lines).
The MMN response peaked at 177 ms from tone onset,
which is consistent with previous studies (cf. Cowan et al.
1993; Garrido et al. 2008). Figure 1B shows a 3D spatiotem-
poral characterization of the MMN response using SPM to
compare the deviant with the standard tones in the placebo
condition. The analysis was performed across the entire
epoch [−100 400] and over all 64 channels. As noted above,
for these analyses the scalp topography at any time bin was
interpolated from 64 channels and smoothed. Figure 1B
shows the SPM where, over subjects, there is a signiﬁcant
negative amplitude deﬂection as a result of the deviant tone [t
(32) = 5.26, P < 0.05, family-wise error corrected]. This result
suggested a signiﬁcant MMN response over bilateral frontal
channels between 160 and 180 ms with maximum at 180 ms.
In the ketamine condition, we also observed a MMN
response over frontal and central electrodes between 110 and
220 ms. Figure 2A shows the grand mean responses across all
subjects in the ketamine condition in response to the deviant
tone (dashed lines) compared with the standard tone (grey).
In the ketamine condition, the MMN response was also
seen in right frontal channels between 140 and 160 ms with a
maximum at 150 ms [t(32) = 5.25, P < 0.05 FWE]. A late
response was observed on the ketamine as well, peaking at
390 ms in central electrodes (Fig. 2B).
Importantly and in accordance with previous studies, the
MMN response was signiﬁcantly attenuated in the ketamine
compared with the placebo condition. Figure 3A illustrates
the difference waveform, which contrasts the deviant tone to
the standard tone, in placebo and ketamine conditions. In the
placebo condition, the MMN response was larger over frontal
and central electrodes between 150 and 180 ms and between
220 and 300 ms.
A paired SPM t-test was performed to compare the MMN
(differences between standard and oddball tones) between
placebo and ketamine conditions. Signiﬁcant differences
between the MMN under placebo and ketamine conditions
were observed [t(16) = 3.68, P < 0.05 corrected for a search
volume deﬁned by the main effect of MMN] in fronto-central
and central electrodes between 220 and 240 ms with a
maximum at 230 ms (Fig. 3B). These results conﬁrm that the
MMN response was signiﬁcantly larger in the placebo com-
pared with the ketamine condition.
DCMs of the MMN Response
As described in section Materials and Methods, we deﬁned a
space of 8 models systematically combining mechanisms of
adaptation in A1 with synaptic plasticity expressed by differ-
ent extrinsic connections of our temporofrontal network.
Random effects BMS indicated that the model with plasticity
in forward and backward connections as well as adaptation
(expressed via post-synaptic gain modulation in A1) had the
largest model evidence and was clearly superior to all other
models at the group level (exceedance probabilities >80% for
placebo and >70% for ketamine; Fig. 4A–C).
Furthermore, we exploited the factorial nature of our
model space to examine the importance of each mechanistic
factor (adaptation and synaptic plasticity, respectively) on its
own. Random effects family-level BMS showed that “adap-
tation models” that allowed for post-synaptic gain modulation
in A1 (models 5–8) were generally superior to models without
adaptation (models 1–4) in both placebo and ketamine con-
ditions (exceedance probabilities >99%), regardless of synap-
tic plasticity elsewhere in the model (Fig. 4D,E). Conversely,
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models that allowed for the expression of synaptic plasticity at
inter-regional connections (models 2–4, 6–8) were generally
superior to models without such plasticity (models 1 and 5)
in both placebo and ketamine conditions (exceedance prob-
abilities >99%), regardless of whether the model included
adaptation or not (Fig. 4F,G).
Effects of Ketamine
To examine the effects of ketamine on mechanisms under-
lying the NMDAR-dependence of the MMN response, we com-
pared the parameter estimates from subject-speciﬁc DCMs
that were averaged (using BMA) separately for placebo and
ketamine conditions. First, we used a multivariate Hotelling’s
T2 test to examine whether the distinct sets of parameter esti-
mates encoding neuronal adaptation and short-term synaptic
plasticity, respectively, were signiﬁcantly different between
ketamine and placebo conditions. This drug-induced differ-
ence was signiﬁcant for the parameter set representing synap-
tic plasticity (T = 14.771 with P < 0.023), but not for the
parameter set representing neuronal adaptation (T = 0.217
with P = 0.897). In other words, while adaptation was critical
for explaining the MMN (see above), it did not change under
ketamine compared with placebo. Based on this result we
used, in a second step, univariate post hoc t-tests, asking
where in the network synaptic plasticity was affected by keta-
mine (i.e., at which of the 6 forward and backward connec-
tions in the model). We found a signiﬁcant reduction of
synaptic plasticity, following ketamine administration, of the
forward connection from the left A1 to the left STG (Fig. 5A,B
and Table 1). In other words, under placebo, the left A1→
STG connection almost doubled in strength when a deviant
tone was presented; in contrast, under ketamine, this increase
was almost absent (Fig. 5B; note that the modulatory par-
ameters in DCM for ERPs are scaling coefﬁcients, not additive
contributions as in DCM for fMRI).
Notably, this effect of ketamine on synaptic plasticity re-
mained signiﬁcant after Bonferroni-correction for multiple
comparisons (t = 4.60, P < 0.001). Furthermore, there was a
trend toward a signiﬁcant reduction in the forward connection
from the right A1 to the right STG (t = 1.55, P = 0.14).
Finally, we related this selective effect of ketamine on plas-
ticity of the left A1→ STG connection to the impact of keta-
mine on subjects’ ASC questionnaire scores. Speciﬁcally,
Schmidt et al. (2012) had reported an effect of ketamine on
the “control and cognition” subscale of the ASC, and we now
tested, using a simple linear regression analysis, whether this
effect of ketamine might be explained through its effects on
plasticity of the left A1→ STG connection. Indeed, there was a
signiﬁcant linear relation between drug effects on “control
and cognition” ratings (score under ketamine minus score
under placebo) and drug effects on plasticity (ratios of
condition-speciﬁc changes in coupling, that is, relative plas-
ticity under ketamine vs. placebo) of the left A1→ STG con-
nection (F = 5.53, P < 0.03).
Figure 1. (A) Grand average ERP responses in the placebo condition to the sixth tone of stimulus trains (“standard tone”; black line) and the ﬁrst tone of stimulus trains
(“deviant” tone; dashed line) across frontal and central electrodes. (B) Spatiotemporal SPM representation of the MMN response in the placebo condition: Comparison between
the ﬁrst and the sixth tone presentations, the “deviant” and the “standard”, respectively. SPM analysis was performed across all 64 channels and across the entire epoch [−100
400]. The SPM results show a signiﬁcant negative difference over bilateral frontal electrodes in the range of 160 and 180 ms, peaking at 177 ms.
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Figure 2. (A) Grand average ERP responses in the ketamine condition to the sixth tone of stimulus trains (“standard tone”; black line) and the ﬁrst tone of stimulus trains
(“deviant” tone; dashed line) across frontal and central electrodes. (B) Spatiotemporal SPM representation of the MMN response in the ketamine condition: Comparison between
the ﬁrst and the sixth tone presentations, the “deviant” and the “standard”, respectively. SPM analysis was performed across all 64 channels and across the entire epoch [−100
400]. Similarly to the placebo group, the SPM results show a signiﬁcant negative difference over right frontal electrodes in the range of 140 and 160 ms, peaking at 150 ms.
Figure 3. (A) Grand average difference MMN waveform in placebo (black line) and ketamine (grey line) conditions across frontal and central electrodes. (B) Spatiotemporal
representation of the effect of ketamine administration: Comparison of the MMN between placebo and ketamine conditions. SPM analysis was performed across all 64 channels
and across the entire epoch [−100 400]. The SPM results show a signiﬁcantly larger MMN in the placebo condition compared with the ketamine condition over frontal and
central electrodes in the range of 220 and 240 ms, peaking at 230 ms.
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Discussion
In this paper, we present a model-based investigation of the
physiological mechanisms that underlie the well-established
reduction of the MMN following administration of the
NMDAR antagonist ketamine. Speciﬁcally, we used DCM and
BMS to analyze data from a recent study by Schmidt et al.
(2012) of healthy volunteers during a roving MMN paradigm
with a cross-over, double-blind, placebo-controlled design. In
the following, we summarize the results of our model-based
investigations, discuss their implications and consider poten-
tial limitations of our study.
In a ﬁrst step, we veriﬁed that we could replicate the results
of a previous DCM study of the roving MMN paradigm
(Garrido et al. 2008). Speciﬁcally, we speciﬁed a set of 8
models that differed systematically in 1) whether or not they
allowed for a differential expression of adaptation (post-
synaptic sensitivity) during standard and deviant stimuli and
2) which connections were allowed to change—show short-
term plasticity—between deviant and standard stimuli. These
models were very similar to those of Garrido et al. (2008)
except that we added interhemispheric connections at the
level of both primary and secondary auditory areas (Fig. 4).
These connections do not change the relative evidence for
different models, but increase the overall model evidence. Re-
assuringly, our model selection results replicate those by
Garrido et al. (2008): Regardless of the drug condition, both
Figure 4. Model speciﬁcation. (A) The 8 DCMs used for Bayesian model comparison. Auditory input ﬁrst affects the primary auditory cortex, from where activity is propagated
to the remaining sources. Dotted lines indicate which connections were allowed to show condition-speciﬁc (oddball vs. standard) changes: Adaptation and synaptic plasticity are
modeled by changes in post-synaptic gain and effective connectivity. (B and C) Random effects Bayesian model comparison showed that the model with synaptic plasticity
(modulation of connection strength) in both forward and backward connections as well as adaptation in A1 (post-synaptic gain modulation) had the greatest evidence over both
placebo and ketamine conditions. (D and E) Family-wise Bayesian model selection showed that the presence of adaptation (post-synaptic gain modulation) improved the models
considerably, regardless of the presence of synaptic plasticity. (F and G) Family-wise Bayesian model selection showed that the presence of synaptic plasticity improved the
models considerably, regardless of the presence of adaptation.
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adaptation in the primary auditory cortex and short-term
plasticity of forward and backward connections across the
auditory hierarchy markedly improved the model evidence
(Fig. 4). In other words, as postulated by MMN theories
resting on the free-energy principle (Garrido, Kilner, Stephan,
et al. 2009), both adaptation and synaptic plasticity are re-
quired to explain the MMN generation per se.
While both adaptation and plasticity of forward and back-
ward connections were required to explain MMN, which of
these mechanisms, if any, would be attenuated by ketamine?
Using BMA (Penny et al. 2010), we asked whether ketamine
effects on the MMN generation were reliably modelled by
DCM such that the pharmacological effects were clearly re-
ﬂected in the model parameters (changes in coupling). To
this end, we used a multivariate Hotelling’s T2 test, testing
separately whether the parameter estimates encoding neur-
onal adaptation and short-term synaptic plasticity, were sig-
niﬁcantly different between ketamine and placebo conditions.
This drug-induced difference was signiﬁcant for the par-
ameters representing synaptic plasticity, but not adaptation.
We then proceeded to ask, using univariate t-tests, which of
the 6 forward and backward connections were most critical
for explaining the ketamine effects. Correcting for multiple
comparisons, we found that only plasticity in the forward con-
nection from the left A1 to the left STG showed a signiﬁcant
change under ketamine, compared with placebo. A similar
trend was observed for the homologous forward connection
from right A1 to right STG, but this did not quite reach
signiﬁcance.
Finally, we examined whether our model-based estimates of
ketamine-induced attenuation of short-term plasticity in the left
A1→ STG connection correlated with a measure of ketamine-
induced change in cognition. The previous study by Schmidt
et al. (2012) had found a correlation between relative
ketamine-induced impairments of subjective ratings of
impaired control and cognition (subsuming items for disor-
dered thought and loss of control over body and thought) and
the MMN “slope” under placebo, which indexes the systematic
Figure 5. (A) The plasticity of the forward connection from the left A1 to the left STG was signiﬁcantly reduced after ketamine administration (P<0.001). (B) The y-axis
denotes the average value (±standard deviation) of the (scaling) parameter that encodes changes in connection strength for deviant versus standard tones. (B) Linear regression
indicated a signiﬁcant relation between drug effects on “control and cognition” ratings (score under ketamine minus score under placebo) and drug effects on plasticity (ratios of
DCM parameters encoding condition-speciﬁc changes, that is, relative short-term plasticity under ketamine vs. placebo) in the left A1→ STG connection (F= 4.45, P<0.006).
Table 1
Paired t-test results ((N= 17): Reductions in forward and backward plasticity (condition-speciﬁc
changes in connectivity) in the ketamine compared with the placebo condition
Paired
differences
mean
Standard
deviation
Standard
error
mean
t Signiﬁcance
(2-tailed)
Left A1 > left STG 0.94 0.84 0.20 4.60 0.0001*
Right A1 > right STG 0.79 2.10 0.51 1.55 0.140
Right STG > right IFG 0.56 1.65 0.40 1.40 0.180
Left STG > left A1 0.28 2.46 0.60 0.47 0.646
Right STG > right A1 0.20 0.99 0.24 0.81 0.428
Right IFG > right STG 0.68 2.55 0.62 1.11 0.285
*FWE P< 0.05.
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increase in MMN amplitude with the number of preceding stan-
dards (a speciﬁc index of prediction error processing). In brief,
the previous study showed that MMN expression under
placebo predicted the effects of ketamine on introspective
ratings of symptoms that are reminiscent of schizophrenic
symptoms (e.g., thought disorder). Our present analyses
suggest a more ﬁne-grained interpretation of this relationship:
Our model-based analyses report a signiﬁcant correlation
between ketamine effects on short-term plasticity of the left
A1→ STG connection and ketamine-induced changes in
“control and cognition” ratings. In other words, we empirically
demonstrated that blocking NMDARs by ketamine leads to im-
paired plasticity by reducing changes in connection strength
from the left A1 to the left STG, the extent of which predicted
signiﬁcant S-ketamine-induced psychopathology. It is interest-
ing to note that ketamine selectively exerted effects on the left,
but not right A1→ STG connection. This hemispheric asymme-
try is reminiscent of the left-hemispheric dominance of inner
speech that has been linked to disordered thought in schizo-
phrenia, for example, Strik et al. 2008. However, this is clearly
a speculative observation at the present time.
Why should a disruption of NMDAR-dependent synaptic
plasticity predict changes in the “control and cognition” sub-
scale of the ASC questionnaire? For example, one may
wonder whether a phenomenon like the MMN may be too
“low-level” a phenomenon to be informative with regard to
“high-level” cognitive control processes as probed by the ASC
questionnaire. A contrary perspective is that impairments of
perceptual inference, even when they originate from early
stages of information processing, may percolate throughout
the processing hierarchy and induce signiﬁcant disturbances
at all levels (cf. Leitman et al. 2010). This is predicted by hier-
archical Bayesian accounts of brain function, which consider
abnormal prediction error signals as one potential cause of
maladaptive cognition. Several authors have offered expla-
nations how deﬁcient prediction error processing may lead to
impaired learning and suboptimal inference on environmental
causes of sensory inputs, with consequences for adaptive cog-
nition in general, and how this might explain a wide range of
cognitive symptoms, for example, in psychosis (e.g., Friston
2005; Stephan, Friston, et al. 2009; Fletcher & Frith 2009;
Corlett et al. 2011). Assuming that the MMN does indeed rep-
resent implicit trial-by-trial encoding of prediction errors that
depends on NMDAR-dependent plasticity at glutamatergic sy-
napses (cf. Stephan et al. 2006), our ﬁnding that the extent of
ketamine-induced disruption of synaptic plasticity predicts
impairments in cognitive control across subjects is in line with
this general perspective.
However, it is important to emphasize that we do not wish
to make any claims of speciﬁcity here. Our psychological
measures relate to recently developed subscales of one
speciﬁc questionnaire, the ASC, which is particularly useful
for investigating changes in conscious state under drug inﬂu-
ence. The items which relate most closely to cognitive impair-
ments in schizophrenia (e.g., concerning disordered thought
and loss of cognitive or executive control), are contained by
the “control and cognition” subscale (Studerus et al. 2010).
While this is the subscale that correlates with our model-
based estimates of synaptic plasticity, it certainly does not
provide a full coverage of all aspects of psychopathology that
may be linked to schizophrenia or other psychoses. Whether
model-based estimates of synaptic plasticity, as obtained in
the present study, are also associated with other psychopatho-
logically relevant symptoms therefore remains to be tested in
future studies.
Our results are consistent with the free-energy account of
the MMN in that they highlight the importance of both adap-
tation (in the primary auditory cortex) and short-term plas-
ticity (of inter-regional connections) for the generation of the
MMN. Put simply, the sensory learning that is assumed to
underlie the MMN calls on associative plasticity in the extrin-
sic connections communicating predictions and prediction
errors between levels of the auditory hierarchy. As the
oddball is repeated, sensory learning produces more efﬁcient
predictions of auditory stimuli and a decrease in effective con-
nectivity of extrinsic connections (as the oddball becomes a
standard). Our analyses suggest that this decrease is elimi-
nated by ketamine—consistent with its antagonism of
NMDAR-dependent plasticity. Adaptation—or changes in
post-synaptic gain—is thought, in the context of predictive
coding, to encode the precision of bottom-up information.
This precision is itself optimized as a function of stimulus rep-
etition. The present results suggest that this neuromodulatory
optimization may be less sensitive to the NMDAR blockade.
This lack of a signiﬁcant ketamine effect on the parameter
set encoding neuronal adaptation during the MMN generation
ﬁts well to recent results from invasive recordings (multiunit
activity) in the auditory cortex of awake rodents, showing no
effect of NMDAR antagonists on neuronal adaption during the
MMN paradigm (Farley et al. 2010). Nevertheless, based on
our present study, we cannot preclude a NMDAR-mediated
effect on adaptation processes involved in human MMN
expression. This is because our model contains a speciﬁc
(and rather simple) mathematical representation of adaptation
processes, expressed in terms of post-synaptic gain modu-
lation (i.e., drug-dependent changes in the amplitude of the
synaptic kernel of our neural mass model) and may fail to
capture aspects of neuronal adaption that are not fully cap-
tured by this formulation.
One point of contention, however, may be that our present
analyses identiﬁed a predominant impact of NMDAR antagon-
ism on the plasticity of the “forward” connections of the audi-
tory hierarchy. From the perspective of predictive coding, the
free-energy formulation suggests that forward connections
convey prediction errors, that is, phasic signals requiring fast
synaptic transmission. In contrast, predictive coding regards
backward connections as conveying predictions, which may
be of a more modulatory nature and elicit more enduring
effects. This view draws on the concept of “driving” forward
and “modulatory” backward connections in sensory proces-
sing streams (Sherman and Guillery 1998) and led to propo-
sals (Friston 2005; Corlett et al. 2011) that forward
connections predominantly employ fast AMPARs, whereas the
more modulatory backward connections also engage
NMDARs, whose time constants are an order of magnitude
larger than those of AMPARs. From this perspective, one may
thus have expected our DCMs to identify a predominant effect
of ketamine on the plasticity of backward, rather than
forward, connections. It may be useful to consider, however,
that NMDARs, despite their slower time constants compared
with AMPARs, are nevertheless ionotropic receptors and are
capable of conveying driving effects in the presence of other
excitatory inputs (i.e., once the cell membrane is depolarized;
Daw et al. 1993). Indeed, such “driving” effects of NMDARs
Cerebral Cortex October 2013, V 23 N 10 2403
are established, for example, in the visual (Fox et al. 1990)
and auditory cortices (Kelly and Zhang 2002). In line with
this, the original notion of “driving” and “modulatory” con-
nections, as proposed by Sherman and Guillery (1998), jointly
considers AMPARs and NMDARs as ionotropic receptors for
driving connections and focuses on metabotropic glutamate
receptors (mGluRs) for modulatory (backward) connections.
A second fact that may support the plausibility of our ﬁnd-
ings is that NMDAR antagonists like ketamine have been
found to increase the release of glutamate, and thus lead to
secondary activation of glutamatergic non-NMDA receptors
such as AMPARs (Moghaddam et al. 1997). Assuming that
AMPARs are critical for transmission of prediction errors via
forward connections, it is possible that excessive stimulation
of AMPARs under ketamine could lead to ceiling-like effects,
reducing the discriminability of prediction error signals from
baseline transmission (cf. Corlett et al. 2009). In our context
of the roving MMN, this may mean that standard and deviant
tones are no longer clearly differentiable and transmission via
forward connections does not greatly differ between predict-
able and unpredictable tones, leading to a diminished differ-
ence wave (MMN), as observed, and reduced modulation of
synaptic coupling. Given that the models used in this study
cannot disambiguate effects mediated by AMPA and/or
NMDA receptors, this interpretation must remain speculative
at the present time, but would nicely explain our ﬁnding of
reduced modulation of forward connections by prediction
errors under ketamine.
A ﬁnal point that may be of help for a physiological
interpretation of our results is the role of NMDARs in control-
ling rapid changes in AMPAR conductance (e.g., via phos-
phorylation; Montgomery & Madison 2004). This form of
NMDAR-dependent short-term plasticity has previously been
highlighted as a putative mechanism for prediction error sig-
naling in hierarchical cortical architectures implementing pre-
dictive coding (Stephan, Friston, et al. 2009), with explicit
reference to the MMN (Stephan et al. 2006). From this per-
spective, rapid prediction error signaling via forward connec-
tions may be mediated by AMPARs but under control of
NMDARs. In other words, even if NMDARs do not themselves
transmit prediction error signals via forward connections,
they might control the capacity of AMPARs to do so.
In summary, while it is perfectly plausible that NMDARs
play an important role in synaptic transmission along back-
ward connections, “it is unlikely that NMDA receptors only
signal predictions and AMPA receptors signal prediction
errors; rather there may be a division of labor where AMPA
receptors are relatively more engaged in bottom-up and
NMDA receptors are relatively more involved in top-down
processes” (Corlett et al. 2011). Our present results are in line
with this view and imply a less strict dichotomy between
AMPAR and NMDAR mediated effects at forward and back-
ward connections, respectively, as has sometimes been
suggested previously.
Having said this, it is important to keep in mind that we
used a fairly simplistic model for inferring the physiological
mechanisms of the MNN. While the DCM used in this study
does distinguish between different neuronal populations
(pyramidal cells, granular cells, and inhibitory interneurons),
it does not distinguish between pyramidal cells in supra- and
infragranular layers, which take on different roles within pre-
dictive coding schemes (Friston 2010). Furthermore, while
the model does make a distinction between glutamatergic and
GABAergic synapses, there is no explicit distinction between
fast (AMPA) and slower (NMDA) ionotropic receptors, not to
mention the modulatory contributions from mGluRs. The par-
ameter estimates we obtain from our present model are there-
fore rather coarse, lumped summaries of numerous
physiological processes, and the current estimates obtained
for short-term synaptic plasticity cannot be split up into dis-
tinct contributions from different glutamatergic receptors.
There is, however, recent progress in developing DCMs
that move toward a much more ﬁne grained representation of
synaptic physiology. These “conductance-based” DCMs use a
simpliﬁed Morris-Lecar formulation to infer the relative contri-
butions of separate ion channel types (with different ligand-/
voltage-gated behavior and time constants) to measured
potentials (Marreiros et al. 2010). Recently, this model was ex-
tended to include an explicit NMDAR representation, render-
ing it potentially capable of inferring on differential
contributions of NMDAR- and non-NMDAR–mediated trans-
mission at glutamatergic synapses (Moran, Stephan, et al.
2011). This extended model is currently being validated and
when these studies are complete we will re-examine our
present data using models of this sort.
Another direction for reﬁning the modeling approach of
the current study concerns the selection of data features. In
this study, we computed the MMN by subtracting the ERP to
“standard” tones (operationally deﬁned as the sixth tone),
from “deviating” tones (ﬁrst tone within a new train). This ap-
proach was chosen to allow for the direct comparison of our
results to previous DCM studies of the MMN (Garrido et al.
2008). In a further step, the present models could incorporate
the parametric modulation by standard repetitions, for
example, for studying the effects of ketamine on other data
features obtained from roving oddball designs such as the
“repetition positivity” (Haenschel et al. 2005).
A third and ﬁnal opportunity to complement the analysis
from the present study is to employ recently developed com-
putational models that use the same Bayesian inference fra-
mework as DCM but are agnostic about physiological
mechanisms. Instead, they enable the investigation of
trial-by-trial changes in MMN amplitude from a purely compu-
tational (information theoretic) perspective. In other words,
they help clarifying which computational quantities (e.g., pre-
diction errors or surprise) are reﬂected by the trial-by-trial dy-
namics of MMN expression (Lieder et al. in preparation).
These models, once they are fully established, should enable
us to examine the effects of ketamine on MMN generation
from a complementary perspective.
In summary, the present study has presented a novel model-
based characterization of the effects of NMDAR antagonism
during the MMN roving paradigm. This study is part of
ongoing efforts to establish model-based assays of brain
disease processes; a theme that plays a major role in compu-
tational approaches to dissecting the pathophysiology of spec-
trum diseases, such as schizophrenia, into physiologically
well-deﬁned subgroups (Stephan, Friston, et al. 2009). A
recent proof-of-concept study demonstrated that one can infer,
from scalp MEG recordings, dopaminergic effects of NMDA
and AMPA receptors (Moran, Symmonds, et al. 2011). Further-
more, several validation studies have demonstrated that esti-
mates of glutamatergic synaptic physiology—obtained using a
DCM that is similar to the DCM used in this study—can be
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obtained from intracerebral and extradural local ﬁeld potential
recordings (Moran et al. 2008; Moran, Jung, et al. 2011). The
present study has extended this program toward inference on
NMDAR-mediated synaptic effects from EEG data. Clearly, the
present study is only a modest step toward non-invasive,
model-based inference on glutamatergic synaptic physiology,
and more sophisticated models and further validation studies
are needed. Eventually, however, we hope that carefully vali-
dated model-based approaches will enable diagnostically
useful applications of MMN recordings in the future, for
example, for pathophysiologically grounded diagnostic classi-
ﬁcation of spectrum diseases such as schizophrenia (Stephan
et al. 2006).
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